Checked Jun 8, 2026
GLP-1 Telehealth Price Report 2026: what 25 programs actually charge
We checked every published price across 25 US cash-pay GLP-1 telehealth programs. The gap from cheapest to most expensive is $471 a month for the same drug class. Here is what the data shows.
The cheapest published all-in cash price for a GLP-1 telehealth program is $178 a month (Mochi Health, compounded semaglutide). The most expensive cash-pay path with a published all-in is $649 a month (9amHealth, branded medication). That is a $471 a month gap for the same drug class, a 3.6x range, before insurance enters the picture.
- The cash spread is $178 to $649 a month across the 25 programs, a 3.6x range for the same drug class.
- At least 10 of 25 programs advertise a teaser price below the real maintenance cost. The biggest gap is LifeMD: $224 first month, $448 a month ongoing.
- Compounded semaglutide ($178 to $299) undercuts branded Wegovy ($373 to $649 via telehealth, $1,349 retail) for the same active molecule.
- Every confirmed market move in the tracked window was an increase. Noom +$120/mo, Found +$20/mo, Ivim +$25/mo to the floor.
- Insurance cuts the effective cost by up to about 90%, from $373 to $649 cash down to a $25 to $50 copay when prior authorization is approved.
- Compounded tirzepatide runs 22 to 57% below branded Zepbound through these programs.
- Five of 25 programs do not publish a complete maintenance price (Henry Meds, Embla, Strut Health, Lindora, Push Health).
The cash-pay spread, lowest to highest
These are verified all-in monthly maintenance prices (membership plus medication) on a cash-pay basis. Programs marked “insured” quote an insurance-dependent floor, with cash prices substantially higher. Five programs with no published all-in price are listed separately below.
| Program | All-in monthly | Medication | Lock-in |
|---|---|---|---|
| Mochi Health | $178 | Compounded semaglutide | Month-to-month |
| Found | $199 | Compounded semaglutide | 12-month required |
| Ivim Health | $200 (4-mo basis) | Compounded semaglutide | 4-month minimum |
| Eden | $209 | Compounded semaglutide | 3-month minimum |
| Calibrate | $224 (insured) | Branded only | 3-month minimum |
| Sesame Care | $229 | Compounded semaglutide | Month-to-month |
| Noom Med | $249 | Compounded semaglutide | Month-to-month |
| Lemonaid Health | $298 | Compounded semaglutide | Month-to-month |
| Medvi | $299 | Compounded semaglutide | Month-to-month |
| Ro Body | $373 (annual) / $444 (monthly) | Branded only | Month-to-month |
| Hims & Hers | $448 | Branded (Wegovy pill, maintenance) | Month-to-month |
| LifeMD | $448 | Branded (Wegovy pill, maintenance) | Month-to-month |
| Lifeforce | $473 (+ $599 one-time) | Compounded semaglutide | Month-to-month |
| PlushCare | $45 (insured) / $548 (cash) | Branded only | Month-to-month |
| 9amHealth | $649 | Branded (cash) | Month-to-month |
Source: our price index, field for the all-in monthly cost, checked every Monday against each program's published pricing. No published maintenance price: Henry Meds (moved behind signup in June 2026), Embla (employer-only), Strut Health (entry-dose only), Lindora, and Push Health (provider-set marketplace rates).
Teaser price vs real maintenance price
The most common pricing trap is the headline number that applies only to month one or the starter dose. At least 10 of the 25 programs do it. The largest gaps:
| Program | Advertised teaser | Real maintenance | Gap |
|---|---|---|---|
| LifeMD | $224 first month | $448/mo at maintenance dose | +$224/mo |
| Noom Med | $129 to start | $249/mo ongoing | +$120/mo |
| Medvi | $179 first month | $299/mo refill | +$120/mo |
| Eden | $129 first month | $209/mo ongoing | +$80/mo |
| WeightWatchers Clinic | $25/mo for 3 months | $74/mo membership, med separate | +$49/mo |
| Hims & Hers | $39 first-month membership | $448/mo at maintenance dose | membership jumps to $149 |
| Ro Body | $45 first-month membership | $444/mo at maintenance dose | varies by dose |
| Found | $179/mo (old tier) | $199/mo current 12-month plan | +$20/mo |
We list both the entry price and the maintenance price on every program row, and the mechanics are in how GLP-1 telehealth pricing works.
Compounded vs branded, same molecule
The single largest driver of the price spread is compounded versus branded. The active ingredient is the same; the regulatory pathway and the price are not.
| Molecule | Compounded (telehealth) | Branded direct (cash) | Branded retail (cash) | Insured copay |
|---|---|---|---|---|
| Semaglutide | $178 to $299/mo | $299/mo Wegovy pill, $349/mo injection | $1,349/mo (Wegovy) | $25 to $50/mo |
| Tirzepatide | $199 to $349/mo | $299 to $449/mo (Zepbound vials) | $1,099/mo (Zepbound) | $25 to $50/mo |
| Orforglipron (Foundayo) | Not compoundable | $149/mo (lowest dose) | No generic | $25/mo with card |
Retail and direct prices from the Wegovy and Zepbound drug pages. Full path-by-path breakdown in the GLP-1 cost guide.
Price moves so far in 2026
Every confirmed market move in the tracked window (May 25 to June 10, 2026) was upward, except a small cut to one program's first-month intro. No program reduced its ongoing maintenance price.
| Date | Program | Old | New | Direction |
|---|---|---|---|---|
| Jun 5, 2026 | Noom Med | $129/mo (as ongoing) | $249/mo ongoing | Higher |
| Jun 10, 2026 | Found | $179/mo (12-month) | $199/mo (old tier removed) | Higher |
| Jun 10, 2026 | Ivim Health | ~$150/mo (12-mo prepay) | ~$175/mo (tier eliminated) | Higher |
| May 25, 2026 | Hims & Hers | $49 first-month | $39 first-month | Lower (entry only) |
Every price change is logged with a date on the price-change record.
Methodology
We track the all-in monthly cost for each of 25 GLP-1 telehealth programs operating in the United States. All-in means the membership fee plus medication where the program bundles both; where medication bills separately, we report the program fee plus the published cash medication price or, for insurance-first programs, the program fee plus the typical copay. We track the maintenance-dose price, not the starter or intro tier.
Prices are checked every Monday against each program's published pricing page, help center, or official pricing communications. Where a program's live site blocks automated access, we confirm through a web search of the program's own published materials. We do not sign up, pay, or purchase to verify a price; we read the figure the program publishes. Where a program does not publish its maintenance price, we flag the row rather than estimate. All prices are in US dollars, cash-pay, United States only. The tracking window for this report is May 25 to June 10, 2026.
GLP Chart. “GLP-1 Telehealth Price Report 2026.” June 2026. glpchart.com/glp1-price-report-2026. Journalists and researchers are welcome to cite these figures with a link. For the live numbers behind this report, updated every Monday, see the price index.
Frequently asked questions
Why does the same drug cost $178 a month at one program and $1,349 at the pharmacy?
The $178 a month (Mochi Health) is compounded semaglutide, prepared by a 503A pharmacy under prescription. The $1,349 a month is the retail cash price for branded Wegovy, the FDA-approved product from Novo Nordisk. Same active molecule, different regulatory pathway, different manufacturing oversight, very different price. Insurance can cut the branded price to $25 to $50 a month for patients who qualify and get prior authorization approved.
Are the teaser prices legal?
Nothing in the data suggests any program advertises its intro price unlawfully. What is documented is that at least 10 of the 25 programs advertise a first-month or entry-dose price well below the ongoing maintenance cost, sometimes by more than $200 a month. The practice is widespread. A shopper who compares on the advertised entry price and does not read the fine print will be surprised when month two bills.
Which programs have lock-in contracts?
Four require a multi-month commitment for their lowest price: Found (12-month plan for $199 a month cash), WeightWatchers Clinic (12-month commitment), Calibrate (3-month minimum, paid upfront), and Embla (12-month curriculum). Ivim Health requires a 4-month medication prepay to reach its cheapest per-month rate.
How often do GLP-1 prices change?
In the tracked window (May 25 to June 10, 2026), every confirmed market move was an increase. Noom Med's ongoing rate rose $120 a month, Found raised its 12-month plan $20 a month, and Ivim eliminated its cheapest prepay tier, raising the floor by at least $25 a month. The one reduction recorded was Hims cutting its first-month intro by $10, which does not change the ongoing price.
Does insurance actually work for these drugs?
For some patients, yes. PlushCare, Calibrate, Form Health, WeightWatchers Clinic, and 9amHealth are built around insurance-first models for branded Wegovy or Zepbound. When approved, the copay typically runs $25 to $50 a month versus $373 to $649 cash. The catch: prior authorization is not guaranteed, approval can take two or more weeks, and some employers exclude weight-loss GLP-1s entirely. Compounded programs do not accept insurance.
What is the cheapest way to access tirzepatide?
The cheapest published compounded tirzepatide all-in is about $199 to $299 a month. Mochi's tirzepatide tier is $278 a month flat, Noom's GLP-1Rx Plus is $299, and Found starts at $199 on the 12-month plan. The branded alternative, Zepbound vials through LillyDirect, runs $299 to $449 a month cash. Compounded tirzepatide carries the highest active regulatory exposure of any GLP-1 here, with Eli Lilly pursuing litigation against compounders through 2025 and 2026.
See the live chart of all 25 programs →
